Daily non-political popular news in brief.

New research may show why some prostate cancer recurs after treatment

Cancer researchers have long worked to understand why some prostate cancers recur after the use of therapies designed to stop the production of testosterone and other androgens that fuel cancer cell growth. New research has now detected that androgen-synthesizing proteins are present within cancer cells, which suggests that cancer cells may develop the capacity to produce their own androgens.

Read more »

Keywords: research, show, prostate, cancer, recurs, treatment, recur

« Previous | Next »

Similar news on "New research may show why some prostate cancer recurs after treatment":

1. IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
   11-05-2006 · EurekAlert!
   New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. These and other data, including long-term genitourinary side effects, were presented today.
   Similar news · Read more »
   
2. Gene therapy, cancer-killing viruses and new drugs highlight novel approaches to cancer treatment
   04-17-2007 · EurekAlert!
   Studies presented at the 2007 meeting of the American Association for Cancer Research show how researchers are using the new, as well as the natural, to help design and test new drugs to treat cancer.
   Similar news · Read more »
   
3. Prostate cancer more likely to return in blacks than whites, but the disease is not more aggressive
   10-09-2007 · EurekAlert!
   African-American men are more likely to have their prostate cancer return after treatment, but their disease is no more aggressive when it does recur than that of their white counterparts, according to a study led by Duke Prostate Center researchers.
   Similar news · Read more »
   
4. MR imaging helps predict recurrence in prostate cancer patients
   05-04-2007 · EurekAlert!
   MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.
   Similar news · Read more »
   
5. Stress may help cancer cells resist treatment, research shows
   04-10-2007 · EurekAlert!
   Scientists from Wake Forest University School of Medicine are the first to report that the stress hormone epinephrine causes changes in prostate and breast cancer cells that may make them resistant to cell death.
   Similar news · Read more »
   
6. Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
   02-06-2008 · EurekAlert!
   Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.The clinical trial is part of a $9 million grant from the National Cancer Institute awarded to Henry Ford to study the effectiveness of gene therapy to treat prostate cancer.
   Similar news · Read more »
   
7. Studies at cancer conference show new therapies changing outlook for blood cancer patients
   12-08-2006 · EurekAlert!
   The International Myeloma Foundation (IMF) -- conducting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians -- today noted that multiple studies presented at the 2006 Annual Meeting of the American Society of Hematology (ASH) illustrate the breadth of the gains being made in the treatment of multiple myeloma and related blood cancers.
   Similar news · Read more »
   
8. New classification better identifies prostate cancer patients to benefit from hormone therapy
   11-08-2006 · EurekAlert!
   A new classification system for evaluating men after radiation treatment for prostate cancer better determines which men may recur and thus may benefit from hormone therapy. Doctors applied the new system to 1,831 previously treated patients. The new classification could alter the course of treatment, which may include hormone therapy sooner and for more men. The study demonstrates a significant improvement in predicting endpoints, including distant metastasis, cause-specific mortality and overall mortality.
   Similar news · Read more »
   
9. New research supports early testing for prostate cancer
   05-20-2007 · EurekAlert!
   Research presented today during the 102nd Annual Scientific Meeting of the American Urological Association in Anaheim, Calif., provided further evidence supporting regular prostate-cancer screening and offered new insights into disease progression and the hormonal treatment of recurrent disease. A special session for media highlighting this research was held on May 20 at 9:00 a.m. PDT and was moderated by AUA spokesman Christopher L. Amling, M.D.
   Similar news · Read more »
   
10. From clinical cancer research: rethinking therapeutic cancer vaccine trials
    07-03-2007 · EurekAlert!
    Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
    Similar news · Read more »